Key facts
- It has raised $10.0M; the latest was Later Stage VC ($10.0M) in Apr 2025.
- Notable investors include US National Science Foundation, MassChallenge, National Institutes of Health, Downstate's Biotechnology Incubator, Entrepreneurship Lab Bio & Health Tech NYC — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Chemeleon
- ·The full record, as it builds
Funding rounds
No funding rounds for Chemeleon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chemeleon
Developer of a chemical sensor designed to rapidly detect chemical compounds. The company's sensor materials combine highly selective molecular receptors with colorimetric nanomaterial reporters to provide an autonomous and inert means of optically detecting hazardous chemicals in virtually any environment, from clinical to third-world settings, enabling clients to accurately and quickly identify chemicals, obviating the need for slow, complex and expensive lab analysis.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2009
- Employees
- 4
- Website
- chemeleon.com/
- Ownership
- Privately Held (backing)
Chemeleon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chemeleon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chemeleon in its N-PORT filings yet. We sweep new filings monthly.